4.7 Review

Micro and nanoscale technologies in oral drug delivery

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 157, 期 -, 页码 37-62

出版社

ELSEVIER
DOI: 10.1016/j.addr.2020.07.012

关键词

Drug delivery devices; Micro and nanocarriers; Micro and nanoscale technologies; Oral drug delivery; Tissue models

资金

  1. Swiss National Foundation Postdoctoral Fellowship [P2EZP2_187980]
  2. UCSF Health Innovation Via Engineering Postdoctoral Fellowship
  3. Fulbright-Nehru Postdoctoral Fellowship [2395/FNPDR/2018]
  4. British Heart Foundation Centre of Research Excellence [RE/18/4/34215]
  5. Schlumberger Foundation, Faculty for the Future Fellowship
  6. UK Regenerative Medicine Platform Acellular/Smart Materials - 3D Architecture [MR/R015651/1]
  7. Swiss National Science Foundation (SNF) [P2EZP2_187980] Funding Source: Swiss National Science Foundation (SNF)
  8. MRC [MR/R015651/1] Funding Source: UKRI

向作者/读者索取更多资源

Oral administration is a pillar of the pharmaceutical industry and yet it remains challenging to administer hydrophilic therapeutics by the oral route. Smart and controlled oral drug delivery could bypass the physiological barriers that limit the oral delivery of these therapeutics. Micro- and nanoscale technologies, with an unprecedented ability to create, control, and measure micro- or nanoenvironments, have found tremendous applications in biology and medicine. In particular, significant advances have been made in using these technologies for oral drug delivery. In this review, we briefly describe biological barriers to oral drug delivery and micro and nanoscale fabrication technologies. Micro and nanoscale drug carriers fabricated using these technologies, including bioadhesives, microparticles, micropatches, and nanoparticles, are described. Other applications of micro and nanoscale technologies are discussed, including fabrication of devices and tissue engineering models to precisely control or assess oral drug delivery in vivo and in vitro, respectively. Strategies to advance translation of micro and nanotechnologies into clinical trials for oral drug delivery are mentioned. Finally, challenges and future prospects on further integration of micro and nanoscale technologies with oral drug delivery systems are highlighted. (C) 2020 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据